News and Events

BioFocus Enhances Diverse Screening Library through Agreement with ChemBridge

San Diego, California, December 5, 2011

BioFocus, an integrated drug discovery partner, announced that it has enhanced its diverse screening library through a new compound supply agreement with ChemBridge. BioFocus now offers one of the most powerful screening platforms in the industry with over 900,000 unique chemical compounds and approximately 100,000 probes from natural sources. Under the agreement BioFocus has selected ChemBridge compounds to replace a portion of the current screening library, resulting in a collection with significantly increased novelty, structural diversity and lead likeness, while increasing its overall solubility profile.

back to top